ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/08/22 | 1,970 | 2,096 | 1,941 | 2,086 | +116 | +5.9% | 12,291,300 |
| 2023/08/21 | 1,812 | 2,041 | 1,812 | 1,970 | +165 | +9.1% | 11,067,800 |
| 2023/08/18 | 1,751 | 1,805 | 1,666 | 1,805 | +4 | +0.2% | 5,448,900 |
| 2023/08/17 | 1,711 | 1,822 | 1,688 | 1,801 | +88 | +5.1% | 5,403,000 |
| 2023/08/16 | 1,590 | 1,748 | 1,570 | 1,713 | +134 | +8.5% | 6,153,900 |
| 2023/08/15 | 1,398 | 1,598 | 1,385 | 1,579 | +211 | +15.4% | 4,646,000 |
| 2023/08/14 | 1,367 | 1,385 | 1,349 | 1,368 | +25 | +1.9% | 765,500 |
| 2023/08/10 | 1,333 | 1,350 | 1,319 | 1,343 | +2 | +0.1% | 688,700 |
| 2023/08/09 | 1,325 | 1,348 | 1,308 | 1,341 | +14 | +1.1% | 636,200 |
| 2023/08/08 | 1,321 | 1,341 | 1,308 | 1,327 | +2 | +0.2% | 656,100 |
| 2023/08/07 | 1,343 | 1,375 | 1,316 | 1,325 | -21 | -1.6% | 1,754,600 |
| 2023/08/04 | 1,303 | 1,366 | 1,302 | 1,346 | +13 | +1% | 2,247,700 |
| 2023/08/03 | 1,241 | 1,441 | 1,235 | 1,333 | +78 | +6.2% | 4,639,900 |
| 2023/08/02 | 1,281 | 1,294 | 1,248 | 1,255 | -44 | -3.4% | 841,800 |
| 2023/08/01 | 1,291 | 1,314 | 1,273 | 1,299 | +2 | +0.2% | 900,900 |
| 2023/07/31 | 1,279 | 1,312 | 1,251 | 1,297 | +78 | +6.4% | 1,615,000 |
| 2023/07/28 | 1,173 | 1,221 | 1,167 | 1,219 | +37 | +3.1% | 794,900 |
| 2023/07/27 | 1,175 | 1,189 | 1,169 | 1,182 | +1 | +0.1% | 367,700 |
| 2023/07/26 | 1,180 | 1,199 | 1,169 | 1,181 | -11 | -0.9% | 446,500 |
| 2023/07/25 | 1,190 | 1,193 | 1,166 | 1,192 | -6 | -0.5% | 833,300 |
| 2023/07/24 | 1,205 | 1,217 | 1,195 | 1,198 | -12 | -1% | 451,500 |
| 2023/07/21 | 1,200 | 1,219 | 1,189 | 1,210 | +21 | +1.8% | 565,000 |
| 2023/07/20 | 1,208 | 1,209 | 1,188 | 1,189 | -27 | -2.2% | 742,600 |
| 2023/07/19 | 1,211 | 1,223 | 1,201 | 1,216 | -1 | -0.1% | 808,500 |
| 2023/07/18 | 1,231 | 1,242 | 1,208 | 1,217 | +10 | +0.8% | 701,100 |
| 2023/07/14 | 1,240 | 1,257 | 1,203 | 1,207 | -25 | -2% | 827,700 |
| 2023/07/13 | 1,199 | 1,248 | 1,191 | 1,232 | +44 | +3.7% | 1,259,000 |
| 2023/07/12 | 1,223 | 1,232 | 1,181 | 1,188 | -37 | -3% | 1,259,800 |
| 2023/07/11 | 1,239 | 1,263 | 1,222 | 1,225 | -13 | -1.1% | 946,300 |
| 2023/07/10 | 1,260 | 1,286 | 1,232 | 1,238 | -24 | -1.9% | 1,080,800 |
| 2023/07/07 | 1,272 | 1,293 | 1,255 | 1,262 | -12 | -0.9% | 1,238,600 |
| 2023/07/06 | 1,321 | 1,322 | 1,230 | 1,274 | -54 | -4.1% | 2,736,000 |
| 2023/07/05 | 1,360 | 1,364 | 1,318 | 1,328 | -39 | -2.9% | 902,900 |
| 2023/07/04 | 1,418 | 1,442 | 1,366 | 1,367 | -51 | -3.6% | 1,133,800 |
| 2023/07/03 | 1,400 | 1,438 | 1,386 | 1,418 | +18 | +1.3% | 916,700 |
| 2023/06/30 | 1,377 | 1,412 | 1,340 | 1,400 | +23 | +1.7% | 1,196,900 |
| 2023/06/29 | 1,390 | 1,435 | 1,367 | 1,377 | +12 | +0.9% | 2,294,600 |
| 2023/06/28 | 1,465 | 1,474 | 1,328 | 1,365 | -92 | -6.3% | 3,593,200 |
| 2023/06/27 | 1,460 | 1,513 | 1,454 | 1,457 | -43 | -2.9% | 1,560,300 |
| 2023/06/26 | 1,475 | 1,528 | 1,469 | 1,500 | -8 | -0.5% | 1,453,900 |
| 2023/06/23 | 1,632 | 1,633 | 1,491 | 1,508 | -114 | -7% | 3,495,100 |
| 2023/06/22 | 1,586 | 1,694 | 1,581 | 1,622 | +20 | +1.2% | 3,739,600 |
| 2023/06/21 | 1,660 | 1,675 | 1,570 | 1,602 | -41 | -2.5% | 2,864,900 |
| 2023/06/20 | 1,520 | 1,685 | 1,456 | 1,643 | +83 | +5.3% | 6,597,000 |
| 2023/06/19 | 1,552 | 1,657 | 1,530 | 1,560 | +163 | +11.7% | 8,662,900 |
| 2023/06/16 | 1,397 | 1,397 | 1,397 | 1,397 | +300 | +27.3% | 193,800 |
| 2023/06/15 | 1,115 | 1,115 | 1,091 | 1,097 | -21 | -1.9% | 568,700 |
| 2023/06/14 | 1,131 | 1,135 | 1,116 | 1,118 | -10 | -0.9% | 314,700 |
| 2023/06/13 | 1,147 | 1,148 | 1,124 | 1,128 | -8 | -0.7% | 349,200 |
| 2023/06/12 | 1,098 | 1,140 | 1,095 | 1,136 | +37 | +3.4% | 550,900 |
401～
450
件表示中 / 3678件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 180,700円 | +21.7% | +999.9% | 0.00% | 7.52倍 | 2.49倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 持田薬 | 293,400円 | +3.0% | +27.5% | 2.73% | 18.57倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 141,700円 | +3.2% | +4.5% | 3.67% | 16.28倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 208,800円 | +0.4% | -8.4% | 2.54% | 26.80倍 | 1.52倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| クオリプス | 890,000円 | +660.9% | - | 0.00% | - | 12.91倍 |
|
大阪大学発ベンチャー。ｉＰＳ細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
市場注目の銘柄
チャート関連のコラム
